HIV/AIDS continues to disproportionately affect Black Americans, despite overall progress in reducing infection rates.

Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

Nearly half of all new cases in 2022 were in the South. "The frustrating part is we have the tools now to stop it." ...

A new study led by Western researchers is the first to identify a factor that could influence how fast the pocket where human ...

Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor the human immunodeficiency virus (HIV), a discovery that brings medical experts one step closer to a cure ...

Prominent gaps in pediatric and adolescent HIV care translate into priorities that need to be addressed for optimizing care ...

HIV prevention has advanced with lenacapavir, a yearly injection that blocks the virus's replication, providing long-term ...

Why is AIDS a syndrome and not a disease? What is syndrome?Lookman (by SMS) AIDS is the result of untreated HIV (Human Immunodeficiency Virus). Over time, HIV destroys CD4-T white blood cells, ...

More than half of the people living with HIV in Philadelphia are 50 and older, and they face greater risk of frailty and impairment.

The Trump Administration has announced that it intends to slash 90% of USAID's foreign aid contracts, which would eliminate ...

The research sheds important light on "perimenopause," the transition period leading to menopause.Many women in perimenopause assume they're too young to be suffering symptoms related to menopause ...

This can reduce HIV symptoms. It can also lead to: IRIS wasn’t reported in clinical trials of Descovy. However, it has been reported in people with HIV who took medications that contain ...